Protective effects of activated protein C (APC) on free groin flaps after secondary venous stasis in the rat model

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Hemorheology and Microcirculation

• Publication date

  2015-05-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/CH-131803PMID 24254581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Examination of the protective effects of heparin and recombinant tissue plasminogen activator (rtPA) in compromised adipocutaneous free flaps in the rat model using intravital video microscopy

  2015cited by this paper
• MicroRNA expression following activated protein C treatment during septic shock.

  2013cited by this paper
• Simple, fast and reliable perfusion monitoring of microvascular flaps

  2012cited by this paper
• The outcome of prostaglandin‐E1 and dextran‐40 compared to no antithrombotic therapy in head and neck free tissue transfer: Analysis of 1,351 cases in a single center

  2012cited by this paper
• Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients.

  2012cited by this paper
• An Activated Protein C Analog With Reduced Anticoagulant Activity Extends the Therapeutic Window of Tissue Plasminogen Activator for Ischemic Stroke in Rodents

  2012cited by this paper
• Comparison of time-intensity-curve- (TIC-) analysis of contrast-enhanced ultrasound (CEUS) and dynamic contrast-enhanced (DCE) MRI for postoperative control of microcirculation in free flaps – First results and critical comments

  2011cited by this paper
• Intravenous heparin use in digital replantation and revascularization: The Quebec provincial replantation program experience

  2011cited by this paper
• Activated protein C attenuates intestinal reperfusion-induced acute lung injury: an experimental study in a rat model.

  2008cited by this paper
• Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats

  2007cited by this paper
• The promise of protein C.

  2006cited by this paper
• Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities.

  2006cited by this paper
• NON-activated protein C as post-treatment after spinal cord compression injury in rats

  2006cited by this paper
• Platelet–Leukocyte–Endothelial Cell Interactions after Middle Cerebral Artery Occlusion and Reperfusion

  2004cited by this paper
• Congenital and acquired activated protein C resistance.

  2003cited by this paper
• Vitronectin Functions as a Cofactor for Rapid Inhibition of Activated Protein C by Plasminogen Activator Inhibitor-1

  2001cited by this paper
• The long-term effects of pre-treatment with activated protein C in a rat model of compression-induced spinal cord injury

  2000cited by this paper
• Secondary ischaemia in experimental free flaps--treatment by long acting prostacyclin analogues.

  1999cited by this paper
• The 2.8 A crystal structure of Gla‐domainless activated protein C.

  1996cited by this paper
• Signs of patency in small vessel anastomosis.

  1972cited by this paper

• Modified free pectoral skin flaps in rats.

  2015cites this paper
• Author Index Volume 59 (2015)

  2015cites this paper